MIRNA is a collaborative research network working across nine countries in sub-Saharan Africa and South Asia to strengthen maternal immunisation programmes in readiness for the introduction of new life-saving vaccines which will improve foetal and infant health.
Maternal vaccines protect mothers and infants from life-threatening infectious diseases during the most vulnerable stages of life.
A cross-institutional, cross-country consortium representing key regions in Africa and Asia.
Learn about the work MIRNA have been doing to support maternal immunisation acceleration in LMICs
Subscribe to MIRNA's newsletter and follow updates to stay informed about the latest research and activities.
The Malawi–Liverpool–Wellcome (MLW) programme was established in 1995 and is based at Queen Elizabeth Central Hospital in Blantyre. It conducts high-quality research on major health challenges ranging from malaria, ...
Typhoid fever continues to pose a significant public health challenge across many low- and middle-income countries, including Nepal. Caused by the Salmonella typhi bacterium, the disease is primarily transmitted ...
This study aims to assess the prevalence of short birth spacing (SBS) in association with demographic and socio-economic factors in India with special reference to maternal and child health. This study ...
The scientific community is tasked with creating new generalizable knowledge through research. Investigators aim at understanding and improving the world we live in and society ...
HAS BEEN CREATED FOR OPEN LEARNING MODULES AND DISCUSSIONS
Hi everyone, this new group is a place for new members to introduce themselves in the community. Please post to introduce yourself and let others ...
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
SPEAC’s Special Populations team, in collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, has launched an LSR and meta-analysis tool focused on the safety, effectiveness, and immunogenicity of Chikungunya vaccines Read more
